Antifungal Peptide Wound Dressing Kills 99% of Candida Biofilms on Skin with Minimal Tissue Damage

Synthetic peptide dKn2-7 loaded into calcium alginate wound dressing fibers achieved 99% reduction in Candida albicans biofilms on porcine skin with no significant tissue damage, offering a promising antifungal wound care strategy.

RPEP-09290In vitroPreliminary Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in vitro
Evidence
Preliminary Evidence
Sample
N=N/A (in vitro/ex vivo)
Participants
Candida albicans cultures and ex vivo tissue models

What This Study Found

dKn2-7-loaded alginate fibers achieved 99% reduction in Candida albicans biofilms on ex vivo porcine skin at 500 µg/mg loading, with no significant tissue damage and preserved hemostatic function.

Key Numbers

The dressing uses dKn2-7, a synthetic antifungal peptide, incorporated into calcium alginate microfibers for extended release.

How They Did This

In vitro and ex vivo study: dKn2-7 loaded into calcium alginate microfibers at varying concentrations. Characterized release kinetics, calcium release, planktonic and biofilm killing (in vitro), and biofilm reduction on porcine skin (ex vivo). Histological assessment for tissue damage.

Why This Research Matters

Fungal wound infections are increasingly common and difficult to treat, especially in immunocompromised patients. A wound dressing that simultaneously provides hemostasis, wound healing support, and sustained antifungal peptide delivery could address a critical unmet clinical need.

The Bigger Picture

Antimicrobial peptides in wound dressings represent a growing alternative to conventional antifungals. As drug resistance increases, having a peptide-based option that can be delivered locally via a wound dressing could become an essential tool in wound care.

What This Study Doesn't Tell Us

Ex vivo porcine skin model — not tested in live wounds. The burst release profile may not provide sustained antifungal coverage beyond 24 hours. Only tested against C. albicans — other fungal pathogens may respond differently. Manufacturing scalability not addressed.

Questions This Raises

  • ?Would dKn2-7 fibers be effective against other pathogenic fungi (Aspergillus, Cryptococcus)?
  • ?Can the release profile be modified to provide sustained antifungal activity beyond 24 hours?
  • ?How do these dressings perform in animal wound infection models?

Trust & Context

Key Stat:
99% biofilm reduction dKn2-7-loaded alginate fibers eliminated Candida biofilms on porcine skin at 500 µg/mg loading with no tissue damage
Evidence Grade:
Preliminary evidence from in vitro and ex vivo studies. Promising results but requires in vivo wound model validation.
Study Age:
Published in 2024. Advances peptide-based antimicrobial wound dressing technology.
Original Title:
Antifungal peptide-loaded alginate microfiber wound dressing evaluated against Candida albicans in vitro and ex vivo.
Published In:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 205, 114578 (2024)
Database ID:
RPEP-09290

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What makes this wound dressing special?

It combines three functions in one: the calcium alginate base provides wound healing support and blood clotting, while the loaded antifungal peptide dKn2-7 actively fights fungal infections. Most wound dressings can't do all three.

Why use a peptide instead of regular antifungal drugs?

Conventional antifungal drugs face growing resistance problems and can be toxic. Antimicrobial peptides like dKn2-7 kill fungi through a different mechanism that's harder for the pathogen to develop resistance against, and when applied locally in a wound dressing, systemic toxicity is minimized.

Read More on RethinkPeptides

Cite This Study

RPEP-09290·https://rethinkpeptides.com/research/RPEP-09290

APA

Snyder, Sabrina S; Rock, Crystal A; Millenbaugh, Nancy J. (2024). Antifungal peptide-loaded alginate microfiber wound dressing evaluated against Candida albicans in vitro and ex vivo.. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 205, 114578. https://doi.org/10.1016/j.ejpb.2024.114578

MLA

Snyder, Sabrina S, et al. "Antifungal peptide-loaded alginate microfiber wound dressing evaluated against Candida albicans in vitro and ex vivo.." European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2024. https://doi.org/10.1016/j.ejpb.2024.114578

RethinkPeptides

RethinkPeptides Research Database. "Antifungal peptide-loaded alginate microfiber wound dressing..." RPEP-09290. Retrieved from https://rethinkpeptides.com/research/snyder-2024-antifungal-peptideloaded-alginate-microfiber

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.